Stefan Gruenwald

age ~66

from Encinitas, CA

Get Report
Also known as:
  • Stefan Gruewald
  • L Gruenwald
  • U Gruenwald
Phone and address:
450 Jolina Way, Encinitas, CA 92024
7606342283
Related to:
Connected to:

Stefan Gruenwald Phones & Addresses

  • 450 Jolina Way, Encinitas, CA 92024 • 7606342283 • 7606342355
  • 1516 Tzena Way, Encinitas, CA 92024 • 7607531652
  • San Diego, CA
  • Valley Center, CA
  • 450 Jolina Way, Encinitas, CA 92024 • 7609086573

Resumes

Stefan Gruenwald Photo 1

Managing Partner At Genautica

view source
Position:
Chief Technology Officer (CTO) and Co-founder at Diagnomics, Managing Partner at Genautica, Founder at Corporate Governance Partners
Location:
Greater San Diego Area
Industry:
Venture Capital & Private Equity
Work:
Diagnomics - Greater San Diego Area since Apr 2011
Chief Technology Officer (CTO) and Co-founder
Genautica - Greater Los Angeles Area since Jan 2011
Managing Partner
Corporate Governance Partners - Greater San Diego Area since Nov 2009
Founder
Quadraspec Jun 2008 - Nov 2009
Chief Scientific Officer (CSO)
Corporate Governance Partners Nov 2003 - Jun 2008
Founder
Education:
University of California, San Diego 1989 - 1991
Skills:
Venture Capital
Genomics
Protein Expression
Molecular Biology
Cell Biology
jQuery
HTML 5
CSS3
D3
Proteomics
Nanobiotechnology
Start-ups
Baculovirus
Assembly Language
Molecular Oncology
Systems Biology
International Trade
Mergers
Private Equity
Fund Of Funds
Mergers & Acquisitions
Cleantech
Lifesciences
Biotechnology
R&D
Technology Transfer
Physics
Investments
Honor & Awards:
Friends of Paul Ehrlich Award for the best thesis of the year ("summa cum laude")
Languages:
German
Stefan Gruenwald Photo 2

Chief Technology Officer And Co-Founder

view source
Location:
San Diego, CA
Industry:
Venture Capital & Private Equity
Work:
Diagnomics - Greater San Diego Area since Apr 2011
Chief Technology Officer (CTO) and Co-founder
Genautica - Greater Los Angeles Area since Jan 2011
Managing Partner
Corporate Governance Partners - Greater San Diego Area since Nov 2009
Founder
Quadraspec Jun 2008 - Nov 2009
Chief Scientific Officer (CSO)
Corporate Governance Partners Nov 2003 - Jun 2008
Founder
Education:
University of California, San Diego 1989 - 1991
Skills:
Venture Capital
Start Ups
Biotechnology
Genomics
R&D
Mergers and Acquisitions
Molecular Biology
Private Equity
Entrepreneurship
Corporate Development
Technology Transfer
Bioinformatics
Commercialization
Cell Biology
Cancer
Science
Lifesciences
Executive Management
Investments
Licensing
International Trade
Global Business Development
Protein Chemistry
Mergers
Systems Biology
Emerging Markets
Strategic Consulting
Protein Expression
Proteomics
Dna Sequencing
M&A Experience
Nanobiotechnology
Nanotechnology
Biomedical Engineering
Fund of Funds
Physics
Start Up Ventures
Joint Ventures
Turn Around Management
Innovation Management
Baculovirus
Biopharmaceuticals
Technology Evaluation
Jquery
Html 5
Css3
Python
Assembly Language
Molecular Oncology
Cleantech
Interests:
Science and Technology
Languages:
German
English
Certifications:
Data Analysis In Python With Pandas (Link)
Data Analysis In Python With Pandas
Udemy

Us Patents

  • Flow Cytometric Methods For The Concurrent Detection Of Discrete Functional Conformations Of Prb In Single Cells

    view source
  • US Patent:
    6821740, Nov 23, 2004
  • Filed:
    Feb 24, 1999
  • Appl. No.:
    09/256817
  • Inventors:
    Zbigniew Darzynkiewicz - Chappaque NY
    Frank Traganos - New York NY
    Gloria Juan - Sleepy Hollow NY
    Stefan Gruenwald - Encinitas CA
  • Assignee:
    Becton, Dickinson and Company - Franklin Lakes NJ
  • International Classification:
    G01N 33574
  • US Classification:
    435 72, 435 721, 435 723, 435 724, 435 74, 436800
  • Abstract:
    Methods, reagents, and kits are provided that permit flow cytometric determination of the phosphorylation status of retinoblastoma susceptibility gene protein (pRB) in individual cells. Methods are described that permit the hypophosphorylated, active, form of pRB to be measured either as an absolute quantity or as a proportion of total cellular pRB. Further described are methods that permit pRB phosphorylation status to be correlated with cell cycle phase and with protein components of the cell cycle. Screening of chemical compounds for antiproliferative and antineoplastic activity using the flow cytometric assays is demonstrated. Reagent kits that facilitate the subject methods are also provided.

  • Detection Of Protein Conformations In Single Cells

    view source
  • US Patent:
    7070943, Jul 4, 2006
  • Filed:
    Sep 29, 2004
  • Appl. No.:
    10/954097
  • Inventors:
    Zbigniew Darzynkiewicz - Chappaque NY, US
    Frank Traganos - New York NY, US
    Gloria Juan - Sleepy Hollow NY, US
    Stefan Gruenwald - Encinitas CA, US
  • Assignee:
    Becton Dickinson and Company - Franklin Lakes NJ
  • International Classification:
    C12Q 1/68
    G01N 33/574
  • US Classification:
    435 72, 435 6, 435 721, 435 723, 435 724, 435973, 435974, 436813
  • Abstract:
    Methods, reagents, and kits are provided that permit flow cytometric determination of the phosphorylation status of retinoblastoma susceptibility gene protein (pRB) in individual cells. Methods are described that permit the hypophosphorylated, active, form of pRB to be measured either as an absolute quantity or as a proportion of total cellular pRB. Further described are methods that permit pRB phosphorylation status to be correlated with cell cycle phase and with protein components of the cell cycle. Screening of chemical compounds for antiproliferative and antineoplastic activity using the flow cytometric assays is demonstrated. Reagent kits that facilitate the subject methods are also provided.

  • E2A/Pbx1 Fusion Protein Specific Monoclonal Antibodies

    view source
  • US Patent:
    58586822, Jan 12, 1999
  • Filed:
    Aug 2, 1996
  • Appl. No.:
    8/691997
  • Inventors:
    Stefan Gruenwald - Encinitas CA
    Craig Monell - La Jolla CA
  • Assignee:
    Pharmingen - San Diego CA
  • International Classification:
    G01N 33567
    G01N 3353
    G01N 33543
    C07K 1600
  • US Classification:
    435 71
  • Abstract:
    A monoclonal antibody which specifically binds with an E2A/pbx1 fusion epitope.
Name / Title
Company / Classification
Phones & Addresses
Stefan Gruenwald
CTO
Orbigen Inc
Internet · Biotechnology · Research & Development in Biotechnology · Management Consulting Services
6827 Nancy Rdg Dr, San Diego, CA 92121
8583622028, 8583622030

Googleplus

Stefan Gruenwald Photo 3

Stefan Gruenwald

Work:
CG Funding - Founder (2004)
Genautica - Managing Member (2010)
Diagnomics - CTO (2010)
Orbigen - President (2000-2004)
Becton Dickinson - VP R&D (1997-2000)
PharMingen - VP R&D (1991-1997)
Education:
Johann Wolfgang Goethe University of Frankfurt am Main - Medicine, Johann Wolfgang Goethe University of Frankfurt am Main - Protein Chemistry, Scripps, La Jolla - Immunology, UCSD - Molecular Biology
Tagline:
Scientist, futurist, medical doctor
Get Report for Stefan Gruenwald from Encinitas, CA, age ~66
Control profile